MétaCan
Menu
Back to cohort
Record W4409250038 · doi:10.1097/jcp.0000000000001990

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II

2025· letter· en· W4409250038 on OpenAlexfundno aff
José de León, Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome, Christoph U. Correll, Robert O. Cotes, John M. Davis, Lynn E. DeLisi, Justin Faden, Oliver Freudenreich, David R. Goldsmith, Ronald J. Gurrera, Richard C. Josiassen, John M. Kane, Deanna L. Kelly, Matcheri S. Keshavan, Robert S. Laitman, Y. W. Francis Lam, Jonathan G. Leung, Raymond C. Love, Betsy McCollum, Ian R. McGrane, Jonathan M. Meyer, Henry A. Nasrallah, Frederick C. Nucifora, Anthony J. Rothschild, José M. Rubio, Martha Sajatovic, Deepak K. Sarpal, Georgios Schoretsanitis, Mujeeb U. Shad, Charles Shelton, Leo Sher, Balwinder Singh, Sandarsh Surya, Theodore R. Zarzar, Emílio J. Sanz, Carlos De las Cuevas

Bibliographic record

VenueJournal of Clinical Psychopharmacology · 2025
Typeletter
Languageen
FieldMedicine
TopicSchizophrenia research and treatment
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesPatient-Centered Outcomes Research InstituteH. Lundbeck A/SCenters for Disease Control and PreventionGeorgia Clinical and Translational Science AllianceEpilepsy SocietySunovionJohns Hopkins UniversityNational Institute of Mental HealthInternational Society for Bipolar DisordersTeva Pharmaceutical IndustriesAllerganNational Institutes of HealthHLS TherapeuticsSage TherapeuticsDaiichi Sankyo EuropeWorld Health OrganizationIndiviorBristol-Myers Squibb
KeywordsClozapineMedicineNeutropeniaMyocarditisPackage insertPharmacovigilanceIntensive care medicinePneumoniaPediatricsPsychiatryInternal medicineAdverse effectSchizophrenia (object-oriented programming)Pharmacology

Abstract

fetched live from OpenAlex

PURPOSE/BACKGROUND: This is the second part of a 2-part article that proposes improving the United States (US) clozapine package insert. Part II focuses on fatal outcomes and the 5 boxed warnings, 4 specifically for clozapine: severe neutropenia, seizure, orthostatic hypotension and myocarditis, and 1 for all antipsychotics (elderly with dementia). METHODS: US reports to the World Health Organization's global pharmacovigilance database were analyzed from clozapine's introduction to January 15, 2023. FINDINGS/RESULTS: The US was the top reporter worldwide for clozapine with 56,003 reports and 9587 associated fatal outcomes. The 4 clozapine boxed warnings were associated with 534 fatal outcomes (218 with severe neutropenia, 131 with seizures, 125 with orthostasis, 36 with myocarditis, 24 with cardiomyopathy, and 0 with mitral valve prolapse). With no boxed warnings, pneumonia was associated with 674 fatal outcomes and increased white blood cell count (a sign of infection) with 596 fatal outcomes. After considering overlaps, pneumonia and increases in white blood cell count explained 900 fatalities, or 9.4% of 9587 fatal outcomes. The Food and Drug Administration continues to focus on severe neutropenia which was associated with only 218 or 2.3% of fatal outcomes, whereas 97.7% of fatal outcomes reported in US clozapine-treated patients had another cause. IMPLICATIONS/CONCLUSIONS: To help prevent future deaths in clozapine-treated patients, the clozapine package insert should focus on fatal outcomes during infections. Part II offers detailed solutions regarding current boxed warnings and lack of a warning for pneumonia and other infections. The Supplementary Material includes letters of support from 124 non-US clozapine experts from 44 countries/regions who support Parts I and II.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.081
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0010.007
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.059
GPT teacher head0.437
Teacher spread0.378 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical PsychopharmacologySame topicSchizophrenia research and treatmentFrench-language works237,207